Expression of drug-resistance-related proteins in nasopharyngeal cancer (NPC) patients treated with cisplatin-based concurrent chemoradiotherapy

MLA

M-J. Ahn, et al. “Expression of Drug-Resistance-Related Proteins in Nasopharyngeal Cancer (NPC) Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy.” Journal of Clinical Oncology, vol. 28, May 2010, p. 5551. EBSCOhost, https://doi.org/10.1200/jco.2010.28.15_suppl.5551.

APA

M-J. Ahn, Sunmi Kang, J.W. Kim, Ji-Youn Han, Chung Yong Kim, Hyunna Lee, Young Sil Hwang, Jung-Joo Choi, & Ji Yun Jeong. (2010). Expression of drug-resistance-related proteins in nasopharyngeal cancer (NPC) patients treated with cisplatin-based concurrent chemoradiotherapy. Journal of Clinical Oncology, 28, 5551. https://doi.org/10.1200/jco.2010.28.15_suppl.5551

Chicago

M-J. Ahn, Sunmi Kang, J.W. Kim, Ji-Youn Han, Chung Yong Kim, Hyunna Lee, Young Sil Hwang, Jung-Joo Choi, and Ji Yun Jeong. 2010. “Expression of Drug-Resistance-Related Proteins in Nasopharyngeal Cancer (NPC) Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy.” Journal of Clinical Oncology 28 (May): 5551. doi:10.1200/jco.2010.28.15_suppl.5551.